Search

Your search keyword '"Cole ED"' showing total 13 results
Start Over Author "Cole ED" Publication Type Electronic Resources
13 results on '"Cole ED"'

1. The Cambridge Companion to Masaccio

Author

Ahl, Diane Cole, ed., Ahl, Diane Cole, ed., Ahl, Diane Cole, ed., and Ahl, Diane Cole, ed.

Abstract

The Medieval Review, (dlps) baj9928.0407.005, (tmr) 04.07.05, http://quod.lib.umich.edu/t/text/accesspolicy.html

Published
2002

2. The Cambridge Companion to Masaccio

Author

Ahl, Diane Cole, ed., Ahl, Diane Cole, ed., Ahl, Diane Cole, ed., and Ahl, Diane Cole, ed.

Abstract

The Medieval Review, (dlps) baj9928.0407.005, (tmr) 04.07.05, http://quod.lib.umich.edu/t/text/accesspolicy.html

Published
2002

3. Cerebrovascular events in renal transplant recipients

Author

Abedini, Sadollah, Holme, Ingar, Fellström, Bengt, Jardine, Alan, Cole, Ed, Maes, Bart, Holdaas, Hallvard, Abedini, Sadollah, Holme, Ingar, Fellström, Bengt, Jardine, Alan, Cole, Ed, Maes, Bart, and Holdaas, Hallvard

Abstract

BACKGROUND: The incidence of stroke and risk factors for different subtypes of cerebrovascular (CBV) events in renal transplant recipients have not been examined in any large prospective controlled trial. METHODS: The Assessment of Lescol in Renal Transplantation was a randomized, double-blind, placebo-controlled study of the effect of fluvastatin (40-80 mg) daily on cardiovascular, and renal outcomes in renal transplant recipients. Patients initially randomized to fluvastatin or placebo in the 5 to 6 year trial was offered open-label fluvastatin in a 2-year extension to the original study. We investigated the incidence of stroke and risk factors for ischemic and hemorrhagic CBV events in 2102 renal graft recipients participating in the Assessment of Lescol in Renal Transplantation core and extension trial with a mean follow-up of 6.7 years. RESULTS: The incidence and type of CBV events did not differ between the lipid lowering arm and the placebo arm. A total of 184 (8.8%, 95% confidence interval 4.6-12.9) of 2102 patients experienced a CBV event during follow-up, corresponding to an incidence of 1.3% CBV event per year. The mortality for patients experiencing a hemorrhagic stroke was 48% (13 of 27), whereas the mortality for ischemic strokes was 6.0% (8 of 133). Diabetes mellitus, previous CBV event, age, and serum creatinine were independent risk factors for cerebral ischemic events. The risk of a hemorrhagic cerebral event was increased by diabetes mellitus, polycystic kidney disease, left ventricular hypertrophy, and systolic blood pressure. INTERPRETATION: Risk factors for CBV events in renal transplant recipients differ according to subtype.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results